Alon Singer

Helixbind, Inc.

NIH Rank #508
  • Top 5% Funded
  • Early Career

NIH Funding · FY2024

Total Funding
$8M
Fiscal year 2024
Grants Awarded
8
Active NIH grants
National Rank
#508
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $8M across 8 grants · National rank #508.

Top grants by award amount

Alon Singer's NIH grant portfolio, ranked by award amount.

  • 2R44AI136064-05A1R44
    Direct-from-specimen identification of pathogens common in endocarditis
    $1M
    award amount
  • 5SB1AI172427-03SB1
    Commercialization Readiness Pilot (CRP) program support for: An Integrated Device for identification of bloodstream infections directly from blood
    $1M
    award amount
  • 5R44AI172441-03R44
    Direct detection and identification of antimicrobial resistance genes in bloodstream infections
    $1M
    award amount
  • 1SB1AI183963-01SB1
    Commercialization Readiness Pilot (CRP) program support for: Ultra-sensitive, direct-from-blood, molecular detection of Borrelia infections.
    $1M
    award amount
  • 1R44AI186712-01R44
    An automated culture-free system for the identification of bloodstream infections direct from blood
    $1M
    award amount
  • 5SB1AI172440-02SB1
    Commercialization Readiness Pilot (CRP) program support for: Direct-from-specimen identification of pathogens common in endocarditis
    $997.2K
    award amount
  • 5R44AI165300-03R44
    Direct from blood identification of bloodstream infections in newborns
    $995.9K
    award amount
  • 5R44AI174578-02R44
    Diagnostic tool for assessment and tracking of microbial load in bloodstream infections
    $985.1K
    award amount

Affiliation

Institutions that have administered grants for Alon Singer.

Affiliated with Helixbind, Inc. (MA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Helixbind, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    Entered Top 50% Nationally
    Ranked #508
  7. 2024
    Entered Top 25% Nationally
    Ranked #508
  8. 2024
    Entered Top 10% Nationally
    Ranked #508
  9. 2024
    Entered Top 5% Nationally
    Ranked #508